JerryAShieldsMD
Ophthalmology • Philadelphia, PAProfessor of Ophthalmology, Thomas Jefferson University
Dr. Shields is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
840 Walnut Street
Suite 1440
Philadelphia, PA 19107Phone+1 215-928-3105Fax+1 215-928-1140
Education & Training
Armed Forces Institute of PathologyResidency, Pathology-Anatomic and Clinical, 1971 - 1971
Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalResidency, Ophthalmology, 1967 - 1970
HCA HealthONE /Presbyterian-St Luke’s Medical CenterInternship, Transitional Year, 1964 - 1965
University of Michigan Medical SchoolClass of 1964
Certifications & Licensure
NY State Medical License 1994 - Present
PA State Medical License 1969 - 2022
MD State Medical License 1994 - 2003- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- National Physician of the Year Award for Clinical Excellence Castle Connolly Medical LTD
- Super Doctor SuperDoctors.com
- Fellow (FACS) American College of Surgeons
- Join now to see all
Clinical Trials
- Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma Start of enrollment: 2014 Apr 01
- Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma Start of enrollment: 2014 Nov 19
Publications & Presentations
PubMed
- 186 citationsIntra-arterial Chemotherapy for Retinoblastoma in 70 Eyes: Outcomes Based on the International Classification of RetinoblastomaCarol L. Shields, Fairooz P. Manjandavida, Sara E. Lally, Giulia Pieretti, Sruthi Arepalli
Ophthalmology. 2014-07-01 - 19 citationsIntra-arterial chemotherapy for retinoblastoma in 341 consecutive eyes (1,292 infusions): comparative analysis of outcomes based on patient age, race, and sex.Carol L. Shields, Philip W. Dockery, Antonio Yaghy, Emily R. Duffner, Hannah J. Levin
Journal of AAPOS. 2021-05-24 - 404 citationsThe International Classification of Retinoblastoma predicts chemoreduction success.Carol L. Shields, Arman Mashayekhi, Angela K. Au, Craig N. Czyz, Ann Leahey
Ophthalmology. 2008-01-01
Journal Articles
- Visual Outcome and Millimeter Incremental Risk of Metastasis in 1780 Patients with Small Choroidal Melanoma Managed by Plaque RadiotherapyLydia Komarnicky, Arman Mashayekhi, Carol L Shields, Laura E Barna, Jerry A Shields, JAMA
- Comparison of Posterior Lamellar Resection Versus Lumpectomy for Initial Management of Localized Tarsal Conjunctival Sebaceous Carcinoma in 54 CasesJerry A Shields, Carol L Shields, Sara E Lally, Indian Journal of Ophthalmology
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
